Industry News
The University of Oxford and Thermo Fisher Scientific ramp up COVID-19 testing capability
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Newly developed recombinant antigens are derived specifically from 2019-nCoV for use in infectious disease research and assay and vaccine development
An advanced end-to-end solution for oncology NGS analysis, interpretation and reporting